Suppr超能文献

相似文献

1
Hostile takeover: fungal protein promotes host cell invasion.
J Clin Invest. 2014 Jan;124(1):74-6. doi: 10.1172/JCI73585. Epub 2013 Dec 20.
2
CotH3 mediates fungal invasion of host cells during mucormycosis.
J Clin Invest. 2014 Jan;124(1):237-50. doi: 10.1172/JCI71349. Epub 2013 Dec 20.
3
Genes Are Necessary for Normal Spore Formation and Virulence in .
mBio. 2023 Feb 28;14(1):e0338622. doi: 10.1128/mbio.03386-22. Epub 2023 Jan 10.
4
An integrated genomic and transcriptomic survey of mucormycosis-causing fungi.
Nat Commun. 2016 Jul 22;7:12218. doi: 10.1038/ncomms12218.
5
PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00746-18. Print 2018 Oct.
6
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
mBio. 2020 Jun 2;11(3):e01087-20. doi: 10.1128/mBio.01087-20.
7
Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.
Virulence. 2017 Nov 17;8(8):1657-1667. doi: 10.1080/21505594.2017.1360460. Epub 2017 Aug 24.
9
Inhibition of EGFR Signaling Protects from Mucormycosis.
mBio. 2018 Aug 14;9(4):e01384-18. doi: 10.1128/mBio.01384-18.
10
Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.
Sci Adv. 2019 Jun 12;5(6):eaaw1327. doi: 10.1126/sciadv.aaw1327. eCollection 2019 Jun.

引用本文的文献

1
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):417-448. doi: 10.1007/s00210-024-03392-1. Epub 2024 Aug 28.
2
Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review.
Front Immunol. 2023 Sep 25;14:1264502. doi: 10.3389/fimmu.2023.1264502. eCollection 2023.
3
Mucormycosis co-infection in COVID-19 patients: An update.
Open Life Sci. 2022 Aug 10;17(1):917-937. doi: 10.1515/biol-2022-0085. eCollection 2022.
5
Resolving the equation between mucormycosis and COVID-19 disease.
Mol Biol Rep. 2022 Apr;49(4):3349-3356. doi: 10.1007/s11033-021-07085-3. Epub 2022 Jan 22.
6
Genes, Pathways, and Mechanisms Involved in the Virulence of Mucorales.
Genes (Basel). 2020 Mar 16;11(3):317. doi: 10.3390/genes11030317.

本文引用的文献

1
CotH3 mediates fungal invasion of host cells during mucormycosis.
J Clin Invest. 2014 Jan;124(1):237-50. doi: 10.1172/JCI71349. Epub 2013 Dec 20.
2
Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system.
PLoS Pathog. 2013;9(8):e1003575. doi: 10.1371/journal.ppat.1003575. Epub 2013 Aug 22.
4
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
Vaccine. 2012 Dec 14;30(52):7594-600. doi: 10.1016/j.vaccine.2012.10.038. Epub 2012 Oct 22.
5
Increasing incidence of mucormycosis in University Hospital, Belgium.
Emerg Infect Dis. 2010 Sep;16(9):1456-8. doi: 10.3201/eid1609.100276.
6
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.
J Clin Invest. 2010 Jun;120(6):1914-24. doi: 10.1172/JCI42164. Epub 2010 May 17.
7
Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.
Emerg Infect Dis. 2009 Sep;15(9):1395-401. doi: 10.3201/eid1509.090334.
8
Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
Clin Infect Dis. 2005 Sep 1;41(5):634-53. doi: 10.1086/432579. Epub 2005 Jul 29.
10
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
N Engl J Med. 2004 Feb 26;350(9):950-2. doi: 10.1056/NEJM200402263500923.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验